VIKING THERAPEUTICS INC (VKTX) Stock Analyst Earnings Estimates
NASDAQ:VKTX - Nasdaq - US92686J1060 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 340.28% | N/A 211.17% | N/A 1,661.20% | N/A 180.54% | N/A 93.23% | N/A 49.78% | N/A 36.82% | ||||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A -21.76% | N/A -30.72% | N/A -38.37% | N/A -17.68% | N/A -47.53% | N/A -41.68% | N/A -28.16% | N/A -24.09% | N/A -18.55% | N/A 20.27% | N/A 84.99% | N/A 1,999.69% | N/A 105.43% | N/A 54.98% | |
| EBIT YoY % growth | -23.47M | -12M 48.87% | -13.85M -15.42% | -19.07M -37.69% | -26.16M -37.18% | -32.69M -24.96% | -42.66M -30.50% | -55.68M -30.52% | -70.36M -26.36% | -100.827M -43.30% | -150.921M -49.68% | N/A -41.16% | N/A -29.44% | N/A -22.24% | N/A 68.98% | N/A 379.47% | N/A 270.55% | N/A 73.96% | N/A 49.20% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -3.56 | -1.00 71.91% | -0.80 20.00% | -0.39 51.25% | -0.36 7.69% | -0.54 -50.00% | -0.72 -33.33% | -0.91 -26.39% | -0.92 -1.10% | -1.00 -8.70% | N/A -62.74% | N/A -36.09% | N/A -15.08% | N/A 96.07% | N/A 4,227.67% | N/A 159.95% | N/A 83.36% | N/A 41.28% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.33 -26.06% | -0.37 -84.24% | -0.41 -88.08% | -0.47 -46.94% | -0.37 -13.59% | -0.40 -9.34% | -0.46 -10.93% | -0.52 -10.63% | -0.36 4.11% | -0.43 -6.33% | -0.49 -6.67% |
| Revenue Q2Q % growth | N/A | N/A | N/A | ||||||||
| EBITDA Q2Q % growth | -47.231M -56.31% | -48.044M -39.95% | -51.324M -46.42% | -58.762M -48.64% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -49.12M -44.16% | -53.538M -57.21% | -59.136M -61.77% | -66.957M -44.81% | -59.976M -22.10% | -67.218M -25.55% | -80.784M -36.61% | -94.35M -40.91% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.32 -28.00% | -0.28 | -0.04 | -13.70% |
| Q3 2024 Q2Q % growth | -0.22 4.35% | -0.26 | 0.04 | 14.36% |
| Q2 2024 Q2Q % growth | -0.20 -5.26% | -0.28 | 0.08 | 27.38% |
| Q1 2024 Q2Q % growth | -0.26 -4.00% | -0.28 | 0.02 | 8.31% |
| Q4 2023 Q2Q % growth | -0.25 3.85% | -0.26 | 0.01 | 3.25% |
| Q3 2023 Q2Q % growth | -0.23 -9.52% | -0.22 | -0.01 | -2.92% |
| Q2 2023 Q2Q % growth | -0.19 17.39% | -0.20 | 0.01 | 3.16% |
| Q1 2023 Q2Q % growth | -0.25 -19.05% | -0.24 | -0.01 | -2.12% |
| Q4 2022 Q2Q % growth | -0.26 -62.50% | -0.24 | -0.02 | -9.97% |
| Q3 2022 Q2Q % growth | -0.21 -23.53% | -0.24 | 0.03 | 10.87% |
| Q2 2022 Q2Q % growth | -0.23 -15.00% | -0.22 | -0.01 | -6.36% |
| Q1 2022 Q2Q % growth | -0.21 -10.53% | -0.20 | -0.01 | -5.88% |
| Q4 2021 Q2Q % growth | -0.16 -6.67% | -0.19 | 0.03 | 16.46% |
| Q3 2021 Q2Q % growth | -0.17 -30.77% | -0.21 | 0.04 | 19.48% |
| Q2 2021 Q2Q % growth | -0.20 -53.85% | -0.20 | 0.00 | 0.78% |
| Q1 2021 Q2Q % growth | -0.19 -46.15% | -0.18 | -0.01 | -7.14% |
| Q4 2020 Q2Q % growth | -0.15 -50.00% | -0.16 | 0.01 | 3.59% |
| Q3 2020 Q2Q % growth | -0.13 -62.50% | -0.15 | 0.02 | 16.04% |
| Q2 2020 Q2Q % growth | -0.13 -18.18% | -0.15 | 0.02 | 10.92% |
| Q1 2020 Q2Q % growth | -0.13 -85.71% | -0.12 | -0.01 | -4.93% |
| Q4 2019 Q2Q % growth | -0.10 | -0.13 | 0.03 | 23.45% |
| Q3 2019 Q2Q % growth | -0.08 | -0.13 | 0.05 | 37.84% |
| Q2 2019 Q2Q % growth | -0.11 | -0.09 | -0.02 | -19.83% |
| Q1 2019 Q2Q % growth | -0.07 | -0.09 | 0.02 | 19.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.43% | 2.5% | -5.72% | -3.21% |
| Revenue | N/A | N/A | 0% | -16.67% |